These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 31907045

  • 1. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.
    Li H, Liu B, Ao H, Fu J, Wang Y, Feng Y, Guo Y, Wang X.
    J Nanobiotechnology; 2020 Jan 06; 18(1):4. PubMed ID: 31907045
    [Abstract] [Full Text] [Related]

  • 2. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
    Hong J, Liu Y, Xiao Y, Yang X, Su W, Zhang M, Liao Y, Kuang H, Wang X.
    Drug Deliv; 2017 Nov 06; 24(1):109-120. PubMed ID: 28155567
    [Abstract] [Full Text] [Related]

  • 3. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice.
    Li H, Li Y, Ao H, Bi D, Han M, Guo Y, Wang X.
    Drug Deliv; 2018 Nov 06; 25(1):880-887. PubMed ID: 29608108
    [Abstract] [Full Text] [Related]

  • 4. Annonaceous acetogenins (ACGs) nanosuspensions based on a self-assembly stabilizer and the significantly improved anti-tumor efficacy.
    Hong J, Li Y, Xiao Y, Li Y, Guo Y, Kuang H, Wang X.
    Colloids Surf B Biointerfaces; 2016 Sep 01; 145():319-327. PubMed ID: 27209384
    [Abstract] [Full Text] [Related]

  • 5. A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.
    Mohammad IS, He W, Yin L.
    Pharm Res; 2018 Feb 27; 35(4):77. PubMed ID: 29488114
    [Abstract] [Full Text] [Related]

  • 6. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X, Gou J, Zhang Q, Tan X, Ren T, Yao Q, Tian B, Kou L, Zhang L, Tang X.
    Biomater Sci; 2018 Jun 25; 6(7):1869-1881. PubMed ID: 29808221
    [Abstract] [Full Text] [Related]

  • 7. Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: significantly improved antitumor efficacy.
    Hong J, Li Y, Li Y, Xiao Y, Kuang H, Wang X.
    Int J Nanomedicine; 2016 Jun 25; 11():3239-53. PubMed ID: 27486323
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions.
    Li H, Li M, Fu J, Ao H, Wang W, Wang X.
    Drug Deliv; 2021 Dec 25; 28(1):1226-1236. PubMed ID: 34142631
    [Abstract] [Full Text] [Related]

  • 9. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG1000-HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.
    Yang L, Hong J, Di J, Guo Y, Han M, Liu M, Wang X.
    Int J Nanomedicine; 2017 Dec 25; 12():3681-3695. PubMed ID: 28553107
    [Abstract] [Full Text] [Related]

  • 10. Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer.
    Ao H, Li Y, Li H, Wang Y, Han M, Guo Y, Shi R, Yue F, Wang X.
    Drug Deliv; 2020 Dec 25; 27(1):816-824. PubMed ID: 32489130
    [Abstract] [Full Text] [Related]

  • 11. Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo.
    Huang T, Wang Y, Shen Y, Ao H, Guo Y, Han M, Wang X.
    Sci Rep; 2020 Jun 01; 10(1):8851. PubMed ID: 32483248
    [Abstract] [Full Text] [Related]

  • 12. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
    Chu XY, Huang W, Wang YL, Meng LW, Chen LQ, Jin MJ, Chen L, Gao CH, Ge C, Gao ZG, Gao CS.
    Int J Nanomedicine; 2019 Jun 01; 14():689-705. PubMed ID: 30774330
    [Abstract] [Full Text] [Related]

  • 13. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
    Ren L, Feng W, Shao J, Ma J, Xu M, Zhu BZ, Zheng N, Liu S.
    Theranostics; 2020 Jun 01; 10(14):6384-6398. PubMed ID: 32483459
    [Abstract] [Full Text] [Related]

  • 14. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P, Geng T, Mahanty A, Li T, Zong L, Wang B.
    Int J Pharm; 2019 Feb 25; 557():374-389. PubMed ID: 30610896
    [Abstract] [Full Text] [Related]

  • 15. Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition.
    Wu W, Yu L, Jiang Q, Huo M, Lin H, Wang L, Chen Y, Shi J.
    J Am Chem Soc; 2019 Jul 24; 141(29):11531-11539. PubMed ID: 31251050
    [Abstract] [Full Text] [Related]

  • 16. Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy.
    Hong J, Sun Z, Li Y, Guo Y, Liao Y, Liu M, Wang X.
    Int J Nanomedicine; 2017 Jul 24; 12():5053-5067. PubMed ID: 28765708
    [Abstract] [Full Text] [Related]

  • 17. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn2+ and Synergistic Antitumor Efficacy.
    Zhao YZ, Lin MT, Lan QH, Zhai YY, Xu HL, Xiao J, Kou L, Yao Q.
    Mol Pharm; 2020 Oct 05; 17(10):3857-3869. PubMed ID: 32833457
    [Abstract] [Full Text] [Related]

  • 18. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L, Tian B, Li Y, Lei T, Meng J, Yang L, Zhang Y, Chen F, Zhang H, Xu H, Zhang Y, Tang X.
    ACS Appl Mater Interfaces; 2015 Nov 18; 7(45):25147-61. PubMed ID: 26501354
    [Abstract] [Full Text] [Related]

  • 19. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
    Song W, Tang Z, Lei T, Wen X, Wang G, Zhang D, Deng M, Tang X, Chen X.
    Nanomedicine; 2016 Feb 18; 12(2):377-86. PubMed ID: 26711966
    [Abstract] [Full Text] [Related]

  • 20. Disulfiram-loaded mixed nanoparticles with high drug-loading and plasma stability by reducing the core crystallinity for intravenous delivery.
    Zhuo X, Lei T, Miao L, Chu W, Li X, Luo L, Gou J, Zhang Y, Yin T, He H, Tang X.
    J Colloid Interface Sci; 2018 Nov 01; 529():34-43. PubMed ID: 29883928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.